A month after announcing a partnership with Regeneron to advance its lead gene editor, Tessera Therapeutics has disclosed it will lay off 90 employees. Endpoints News first reported the cuts. Several employees told Endpoints the layoffs will affect about 35% of the workforce. The cuts follow a 17% reduction in 2025 and 13% downsizing in 2024.
All entries for: Tessera Therapeutics
July 24, 2025
Tessera Therapeutics
Layoffs
Somerville, MA
201-500 employees
Tessera Therapeutics will reduce its workforce by 17%, according to reporting from Fierce Biotech, which confirmed the layoffs with a company spokesperson. The move will help support Tessera’s transition into clinical work later this year. It is unclear when the layoffs will take effect or how many exactly will be affected.
Disease Area: Chronic Disease, Multiple, Rare Diseases, Respiratory Diseases
Drug Type: Biologic